Crescita Therapeutics Inc. (TSX:CTX)
Canada · Delayed Price · Currency is CAD 0.7900
0.00 (0.00%)
Inactive · Last trade price on Jun 4, 2026
Crescita Therapeutics Earnings Call Transcripts
Fiscal Year 2024
-
A fully integrated dermatology company highlighted its diverse product portfolio, strong cash position, and recent acquisition of Aquafolia. Growth strategies focus on expanding commercial reach, securing long-term manufacturing contracts, and finding a new U.S. partner for Pliaglis.